quinta-feira, 12 de novembro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· December 4, 2025

Earnings live: Ulta stock pops, HPE falls with guidance in focus

View original at finance.yahoo.com
“For the October quarter, HPE reported adjusted profits of $0.62 per share, compared to estimates of $0.51. Revenue of $9.7 billion grew 14% year over year but came in a bit light compared to estimates, as the Street was expecting $9.9 billion in revenue.”
Verbatim excerpt from the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Enterprises want AI that can work within their secure data environments without compromise

    80% confidence
  • S&P 500 companies that beat earnings saw stock increase by 0.4% on average vs 0.9% five-year average

    80% confidence
  • Celestial AI acquisition strengthens Marvell's position in fastest-growing AI datacenter infrastructure opportunities

    80% confidence
  • All consumers are seeking value, and Dollar Tree thrives at intersection of value-seeking behavior with convenience and discovery

    80% confidence
  • Five Below saw nice traffic growth and growth in both new customers and retention

    80% confidence
  • AI clusters now measured in hundreds of thousands of GPUs and soon millions, pushing interconnect complexity

    80% confidence
  • Strong momentum continued into Q4 including excellent start to holiday season with record-breaking Thanksgiving weekend

    80% confidence
  • 83% of Q3 earnings surprises have been to the upside

    80% confidence
  • Companies that miss earnings saw stock decrease by 5% on average vs 2.6% five-year average

    80% confidence
  • Expansion of value concept beyond $5 price point worked well for growth

    80% confidence
  • Many consumers' wallets are pressured and they are seeking value as we look ahead to the holiday season

    80% confidence
  • Street is underestimating CrowdStrike growth potential as AI Revolution beneficiary

    80% confidence
  • Ulta is confident in plans to drive excitement and deliver for guests during holiday season

    80% confidence
  • Snowflake partnership is meaningful step toward making frontier AI genuinely useful for businesses

    80% confidence
  • Consumer and competitive environment has grown notably tougher for food retailers like Kroger

    80% confidence
  • Sentiment toward food retailers seems to have soured over the past few months

    80% confidence
  • Analysts expect 13.4% jump in S&P 500 EPS during Q3 2025

    80% confidence
  • Q3 sales were strongest in 13 quarters, reflecting acceleration of Bold New Chapter strategy

    80% confidence
  • Q2 results are strongest in Credo's history, reflecting AI training and inference cluster build-out

    80% confidence
  • 95% of S&P 500 companies have reported Q3 earnings as of Nov 21, 2025

    80% confidence
  • Q3 was exceptional quarter with existing customers expanding and net-new customer additions showing strength

    80% confidence

Data points we hold from this source

Snowflake Inc. · product revenue guidance1.19-1.2 billion_USD
Snowflake Inc. · revenue guidance4.44 billion_USD
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Biotech Catalyst Wave: Late-2026 Clinical Readouts, PDUFA Dates and Capital Restructuring
A dense cluster of Q4 2026 to Q1 2027 clinical and regulatory catalysts spans hepatitis delta (Vir's ECLIPSE/SOLSTICE), hypertension and sleep apnea (Mineralys' lorundrostat, PDUFA 2026-12-22), severe hypertriglyceridemia (plozasiran), oncology (ivonescimab BLA, PDUFA 2026-11-14) and gene therapy (Krystal). Positive data flow from AASLD and AHA presentations is offset by cost-cutting guidance, milestones slipping into 2027, and a delisting process that signals capital-market stress for some issuers. Near-term value hinges on binary FDA decisions and Phase 3 topline readouts in Q1 2027.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,995
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,995 factos verificados com a fonte5,565 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Earnings live: Ulta stock pops, HPE falls with guidance in focus — Source | Via News | pt.VIA.NEWS